Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

DNMT3A mutation is associated with increased age and adverse outcome in adult T-acute lymphoblastic leukemia.

Bond J, Touzart A, Leprêtre S, Graux C, Bargetzi M, Lhermitte L, Hypolite G, Leguay T, Hicheri Y, Guillerm G, Bilger K, Lhéritier V, Hunault M, Huguet F, Chalandon Y, Ifrah N, Macintyre E, Dombret H, Asnafi V, Boissel N.

Haematologica. 2019 Jan 17. pii: haematol.2018.197848. doi: 10.3324/haematol.2018.197848. [Epub ahead of print]

2.

PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.

Passet M, Boissel N, Sigaux F, Saillard C, Bargetzi M, Ba I, Thomas X, Graux C, Chalandon Y, Leguay T, Lengliné E, Konopacki J, Quentin S, Delabesse E, Lafage-Pochitaloff M, Pastoret C, Grardel N, Asnafi V, Lhéritier V, Soulier J, Dombret H, Clappier E; Group for Research on Adult ALL (GRAALL).

Blood. 2019 Jan 17;133(3):280-284. doi: 10.1182/blood-2018-10-882142. Epub 2018 Dec 3. No abstract available.

PMID:
30510083
3.

The sympathomimetic agonist mirabegron did not lower JAK2-V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase 2 study SAKK 33/14.

Drexler B, Passweg JR, Tzankov A, Bigler M, Theocharides APA, Cantoni N, Keller P, Stussi G, Ruefer A, Benz R, Favre G, Lundberg P, Nienhold R, Fuhrer A, Biaggi C, Manz MG, Bargetzi M, Mendez-Ferrer S, Skoda RC; Swiss Group for Clinical Cancer Research (SAKK).

Haematologica. 2018 Nov 8. pii: haematol.2018.200014. doi: 10.3324/haematol.2018.200014. [Epub ahead of print]

4.

Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study.

Ghilardi G, Pabst T, Jeker B, Müller R, Cairoli A, Müller AMS, Bargetzi M, Hitz F, Baldomero H, Heim D, Schmidt A, Rossi D, Ghielmini M, Wannesson L, Lerch E, Samaras P, Schanz U, Passweg JR, Stussi G, Kleber M, Gerber B; Swiss Blood Stem Cell Transplantation Registry.

Bone Marrow Transplant. 2018 Nov 2. doi: 10.1038/s41409-018-0379-y. [Epub ahead of print]

PMID:
30390061
5.

Toothache as the initial symptom of plasma cell myeloma.

Wehrhahn T, Bargetzi M, Buitrago-Tellez C, Cantelmi G.

Eur J Dent. 2018 Jul-Sep;12(3):443-445. doi: 10.4103/ejd.ejd_412_17.

6.

Diagnosis and treatment of follicular lymphoma: an update.

Bargetzi M, Baumann R, Cogliatti S, Dietrich PY, Duchosal M, Goede J, Hitz F, Konermann C, Lohri A, Mey U, Novak U, Papachristofilou A, Stenner F, Taverna C, Zander T, Renner C.

Swiss Med Wkly. 2018 Jul 24;148:w14635. doi: 10.4414/smw.2018.14635. eCollection 2018. Review.

7.

Extending shelf life of dithiothreitol-treated panel RBCs to 28 days.

Sigle JP, Mihm B, Suna R, Bargetzi M.

Vox Sang. 2018 May;113(4):397-399. doi: 10.1111/vox.12645. Epub 2018 Mar 7.

PMID:
29512161
8.

Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016.

Passweg JR, Baldomero H, Ansari M, Baerlocher GM, Bargetzi M, Chalandon Y, Duchosal MA, Gerull S, Güngör T, Halter JP, Heim D, Hess U, Leibundgut K, Masouridi-Levrat S, Müller A, Nair G, Pabst T, Renner C, Schmidt A, Stussi G, Nicoloso de Faveri G, Schanz U, For The Swiss Blood Stem Cell Transplantation Group Sbst.

Swiss Med Wkly. 2018 Mar 1;148:w14589. doi: 10.4414/smw.2018.14589. eCollection 2018.

9.

Biological pathways underlying the association of red cell distribution width and adverse clinical outcome: Results of a prospective cohort study.

Zurauskaite G, Meier M, Voegeli A, Koch D, Haubitz S, Kutz A, Bernasconi L, Huber A, Bargetzi M, Mueller B, Schuetz P.

PLoS One. 2018 Jan 17;13(1):e0191280. doi: 10.1371/journal.pone.0191280. eCollection 2018.

10.

Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II Study.

Samaras P, Rütti MF, Seifert B, Bachmann H, Schanz U, Eisenring M, Renner C, Susanne Müller AM, Schmidt A, Mischo A, Fuchs I, Bargetzi M, Manz MG, Stupp R, Petrausch U, Stenner-Liewen F.

Biol Blood Marrow Transplant. 2018 Apr;24(4):694-699. doi: 10.1016/j.bbmt.2017.12.775. Epub 2017 Dec 12.

PMID:
29246820
11.

Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013.

Schnegg-Kaufmann A, Feller A, Baldomero H, Rovo A, Manz MG, Gregor M, Efthymiou A, Bargetzi M, Hess U, Spertini O, Chalandon Y, Passweg JR, Stussi G, Arndt V, Bonadies N; NICER Working Group.

Cancer Epidemiol. 2018 Feb;52:55-62. doi: 10.1016/j.canep.2017.11.008. Epub 2017 Dec 7.

PMID:
29223104
12.

Fungemia and necrotic lymph node infection with Sporopachydermia cereana in a patient with acute myeloid leukemia.

Kingston C, Medinger M, Banderet-Uglioni F, Bassetti S, Bargetzi M, Haubitz S, Fux CA, Bättig V, Goldenberger D, Passweg J, Heizmann M.

Int J Infect Dis. 2017 Aug;61:103-106. doi: 10.1016/j.ijid.2017.06.017. Epub 2017 Jun 23. Review.

13.

Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison.

Baumgartner A, Bargetzi M, Bargetzi A, Zueger N, Medinger M, Passweg J, Schanz U, Samaras P, Chalandon Y, Pichard C, Limonta A, Wannesson L, Pabst T, Duchosal MA, Hess U, Stanga Z, Mueller B, Schuetz P.

Nutrition. 2017 Mar;35:43-50. doi: 10.1016/j.nut.2016.10.007. Epub 2016 Oct 15.

PMID:
28241989
14.

Hematopoietic stem cell remobilization with vinorelbine and filgrastim in AML.

Blum V, Heini AD, Novak U, Taleghani BM, Baerlocher GM, Leibundgut K, Seipel K, Banz Y, Bargetzi M, Pabst T.

Bone Marrow Transplant. 2017 May;52(5):786-788. doi: 10.1038/bmt.2017.2. Epub 2017 Feb 13. No abstract available.

PMID:
28194031
15.

Revisiting nutritional support for allogeneic hematologic stem cell transplantation-a systematic review.

Baumgartner A, Bargetzi A, Zueger N, Bargetzi M, Medinger M, Bounoure L, Gomes F, Stanga Z, Mueller B, Schuetz P.

Bone Marrow Transplant. 2017 Apr;52(4):506-513. doi: 10.1038/bmt.2016.310. Epub 2017 Jan 9. Review.

PMID:
28067888
16.

Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd -line therapy for relapsed and refractory multiple myeloma - a phase II trial.

Mey UJ, Brugger W, Schwarb H, Pederiva S, Schwarzer A, Dechow T, Jehner P, Rauh J, Taverna CJ, Schmid M, Schmidt-Hieber M, Doerfel S, Fischer N, Ruefer A, Ziske C, Knauf W, Cathomas R, von Moos R, Hitz F, Sauter R, Hiendlmeyer E, Cantoni N, Bargetzi M, Driessen C.

Br J Haematol. 2017 Mar;176(5):770-782. doi: 10.1111/bjh.14481. Epub 2016 Dec 16.

PMID:
27983764
17.

Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse.

Gössi F, Spahn M, Zweifel M, Panagiotis S, Mischo A, Stenner F, Hess U, Berthold D, Bargetzi M, Schardt J, Pabst T.

Bone Marrow Transplant. 2017 Feb;52(2):334-336. doi: 10.1038/bmt.2016.285. Epub 2016 Nov 28. No abstract available.

PMID:
27892951
18.

Y90 -Ibritumomab tiuxetan (Y90 -IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05).

Voegeli M, Rondeau S, Berardi Vilei S, Lerch E, Wannesson L, Pabst T, Rentschler J, Bargetzi M, Jost L, Ketterer N, Bischof Delaloye A, Ghielmini M.

Hematol Oncol. 2017 Dec;35(4):576-583. doi: 10.1002/hon.2348. Epub 2016 Sep 28.

PMID:
27677906
19.

Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.

Van Den Neste E, Schmitz N, Mounier N, Gill D, Linch D, Trneny M, Bouadballah R, Radford J, Bargetzi M, Ribrag V, Dührsen U, Ma D, Briere J, Thieblemont C, Bachy E, Moskowitz CH, Glass B, Gisselbrecht C.

Bone Marrow Transplant. 2017 Feb;52(2):216-221. doi: 10.1038/bmt.2016.213. Epub 2016 Sep 19.

PMID:
27643872
20.

Association of Nutritional Parameters with Clinical Outcomes in Patients with Acute Myeloid Leukemia Undergoing Haematopoietic Stem Cell Transplantation.

Baumgartner A, Zueger N, Bargetzi A, Medinger M, Passweg JR, Stanga Z, Mueller B, Bargetzi M, Schuetz P.

Ann Nutr Metab. 2016;69(2):89-98. Epub 2016 Sep 17.

21.

Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients.

Maul JT, Stenner-Liewen F, Seifert B, Pfrommer S, Petrausch U, Kiessling MK, Schanz U, Nair G, Mischo A, Taverna C, Schmidt A, Bargetzi M, Stupp R, Renner C, Samaras P.

J Clin Apher. 2017 Feb;32(1):21-26. doi: 10.1002/jca.21459. Epub 2016 Mar 22.

PMID:
27001243
22.

[Monoclonal gammopathy in family practice].

Bargetzi M.

Praxis (Bern 1994). 2015 Oct 14;104(21):1115. doi: 10.1024/1661-8157/a002148. German. No abstract available.

PMID:
26463901
23.

Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).

Mamot C, Klingbiel D, Hitz F, Renner C, Pabst T, Driessen C, Mey U, Pless M, Bargetzi M, Krasniqi F, Gigli F, Hany T, Samarin A, Biaggi C, Rusterholz C, Dirnhofer S, Zucca E, Martinelli G.

J Clin Oncol. 2015 Aug 10;33(23):2523-9. doi: 10.1200/JCO.2014.58.9846. Epub 2015 Jul 6. Erratum in: J Clin Oncol. 2015 Sep 20;33(27):3074.

PMID:
26150440
24.

Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland.

Samaras P, Bargetzi M, Betticher DC, Duchosal MA, Heim D, Hess U, Ketterer N, Lerch E, Matthes T, Mey U, Pabst T, Taverna C, Zander T, Renner C.

Swiss Med Wkly. 2015 Feb 21;145:w14100. doi: 10.4414/smw.2015.14100. eCollection 2015. Review.

25.

Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study.

Rast AC, Kutz A, Felder S, Faessler L, Steiner D, Laukemann S, Haubitz S, Huber A, Buergi U, Conca A, Reutlinger B, Mueller B, Bargetzi M, Schuetz P.

Dis Markers. 2015;2015:795801. doi: 10.1155/2015/795801. Epub 2015 Mar 15.

26.

Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.

Samaras P, Pfrommer S, Seifert B, Petrausch U, Mischo A, Schmidt A, Schanz U, Nair G, Bargetzi M, Taverna C, Stupp R, Stenner-Liewen F, Renner C.

Biol Blood Marrow Transplant. 2015 Jan;21(1):74-80. doi: 10.1016/j.bbmt.2014.09.020. Epub 2014 Sep 30.

27.

Diagnosis and treatment of mantle cell lymphoma.

Hitz F, Bargetzi M, Cogliatti S, Lohri A, Taverna C, Renner C, Mey U.

Swiss Med Wkly. 2013 Nov 13;143:w13868. doi: 10.4414/smw.2013.13868. eCollection 2013. Review.

28.

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.

Terwijn M, van Putten WL, Kelder A, van der Velden VH, Brooimans RA, Pabst T, Maertens J, Boeckx N, de Greef GE, Valk PJ, Preijers FW, Huijgens PC, Dräger AM, Schanz U, Jongen-Lavrecic M, Biemond BJ, Passweg JR, van Gelder M, Wijermans P, Graux C, Bargetzi M, Legdeur MC, Kuball J, de Weerdt O, Chalandon Y, Hess U, Verdonck LF, Gratama JW, Oussoren YJ, Scholten WJ, Slomp J, Snel AN, Vekemans MC, Löwenberg B, Ossenkoppele GJ, Schuurhuis GJ.

J Clin Oncol. 2013 Nov 1;31(31):3889-97. doi: 10.1200/JCO.2012.45.9628. Epub 2013 Sep 23.

PMID:
24062400
29.

[Pitfalls and challenges of the preanalytical phase in hematology].

Méndez A, Bargetzi M, Huber A, Cantoni N.

Ther Umsch. 2013 Aug;70(8):449-55. doi: 10.1024/0040-5930/a000431. Review. German.

PMID:
23876751
30.

Higher emotional distress in female partners of cancer patients: prevalence and patient-partner interdependencies in a 3-year cohort.

Moser MT, Künzler A, Nussbeck F, Bargetzi M, Znoj HJ.

Psychooncology. 2013 Dec;22(12):2693-701. doi: 10.1002/pon.3331. Epub 2013 Jul 3.

PMID:
23825026
31.

Optimizing triage and hospitalization in adult general medical emergency patients: the triage project.

Schuetz P, Hausfater P, Amin D, Haubitz S, Fässler L, Grolimund E, Kutz A, Schild U, Caldara Z, Regez K, Zhydkov A, Kahles T, Nedeltchev K, von Felten S, De Geest S, Conca A, Schäfer-Keller P, Huber A, Bargetzi M, Buergi U, Sauvin G, Perrig-Chiello P, Reutlinger B, Mueller B.

BMC Emerg Med. 2013 Jul 4;13:12. doi: 10.1186/1471-227X-13-12.

32.

Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07).

Passweg JR, Pabst T, Blum S, Bargetzi M, Li Q, Heim D, Stussi G, Gregor M, Leoncini L, Meyer-Monard S, Brauchli P, Chalandon Y; Swiss Group for Clinical Cancer Research (SAKK).

Leuk Lymphoma. 2014 Jan;55(1):87-91. doi: 10.3109/10428194.2013.790540. Epub 2013 May 2.

PMID:
23547838
33.

ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials.

Böll B, Görgen H, Fuchs M, Pluetschow A, Eich HT, Bargetzi MJ, Weidmann E, Junghanß C, Greil R, Scherpe A, Schmalz O, Eichenauer DA, von Tresckow B, Rothe A, Diehl V, Engert A, Borchmann P.

J Clin Oncol. 2013 Apr 20;31(12):1522-9. doi: 10.1200/JCO.2012.45.4181. Epub 2013 Mar 18.

PMID:
23509310
34.

Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries.

Passweg JR, Baldomero H, Bargetzi M, Bucher C, Chalandon Y, Duchosal MA, Gratwohl A, Güngör T, Hess U, Leibundgut K, de Faveri GN, Ozsahin H, Pabst T, Renner C, Stern M, Stussi G, Schanz U; SBST (Swiss Blood Stem Cell Transplantation Group).

Swiss Med Wkly. 2013 Feb 22;143:w13757. doi: 10.4414/smw.2013.13757. eCollection 2013.

35.

Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.

Gröschel S, Schlenk RF, Engelmann J, Rockova V, Teleanu V, Kühn MW, Eiwen K, Erpelinck C, Havermans M, Lübbert M, Germing U, Schmidt-Wolf IG, Beverloo HB, Schuurhuis GJ, Ossenkoppele GJ, Schlegelberger B, Verdonck LF, Vellenga E, Verhoef G, Vandenberghe P, Pabst T, Bargetzi M, Krauter J, Ganser A, Valk PJ, Löwenberg B, Döhner K, Döhner H, Delwel R.

J Clin Oncol. 2013 Jan 1;31(1):95-103. doi: 10.1200/JCO.2011.41.5505. Epub 2012 Sep 24.

PMID:
23008312
36.

Autotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone).

Wannesson L, Bargetzi M, Cairoli A, Cerutti A, Heim D, Hess U, Lerch E, Pabst T, Renner C, Samaras P, Zucca E.

Leuk Lymphoma. 2013 Jan;54(1):36-40. doi: 10.3109/10428194.2012.702903. Epub 2012 Jul 9.

PMID:
22702653
37.

Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine.

Pabst T, Vellenga E, van Putten W, Schouten HC, Graux C, Vekemans MC, Biemond B, Sonneveld P, Passweg J, Verdonck L, Legdeur MC, Theobald M, Jacky E, Bargetzi M, Maertens J, Ossenkoppele GJ, Löwenberg B; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON); German AML Study Group (AMLSG); Swiss Collaborative Group for Clinical Cancer Research (SAKK).

Blood. 2012 Jun 7;119(23):5367-73. doi: 10.1182/blood-2011-11-389841. Epub 2012 Mar 15.

38.

[Rheumatic symptoms in a malignant disease].

Röpke B, Lüthi U, Bargetzi M, Michot M.

Praxis (Bern 1994). 2012 Feb 29;101(5):333-7. doi: 10.1024/1661-8157/a000859. German.

PMID:
22377982
39.

Immune thrombocytopenia and anticoagulation: the role of romiplostim in the early treatment.

Cantoni N, Heizmann M, Bargetzi M.

Br J Haematol. 2012 Jun;157(5):639-41. doi: 10.1111/j.1365-2141.2012.09051.x. Epub 2012 Feb 14. No abstract available.

PMID:
22329466
40.

A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.

Renner C, Zinzani PL, Gressin R, Klingbiel D, Dietrich PY, Hitz F, Bargetzi M, Mingrone W, Martinelli G, Trojan A, Bouabdallah K, Lohri A, Gyan E, Biaggi C, Cogliatti S, Bertoni F, Ghielmini M, Brauchli P, Ketterer N; Swiss SAKK and French GOELAMS group from European Mantle Cell Lymphoma Network.

Haematologica. 2012 Jul;97(7):1085-91. doi: 10.3324/haematol.2011.053173. Epub 2012 Feb 7.

41.

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia.

Vellenga E, van Putten W, Ossenkoppele GJ, Verdonck LF, Theobald M, Cornelissen JJ, Huijgens PC, Maertens J, Gratwohl A, Schaafsma R, Schanz U, Graux C, Schouten HC, Ferrant A, Bargetzi M, Fey MF, Löwenberg B; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON); Swiss Group for Clinical Cancer Research Collaborative Group (SAKK).

Blood. 2011 Dec 1;118(23):6037-42. doi: 10.1182/blood-2011-07-370247. Epub 2011 Sep 27.

42.

Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour.

Häne A, Bargetzi M, Hewer E, Bruehlmeier M, Khamis A, Roelcke U.

J Neurol. 2011 Feb;258(2):318-20. doi: 10.1007/s00415-010-5722-1. Epub 2010 Aug 29. No abstract available.

PMID:
20803212
43.

[Distress among cancer patients and their partners in the first year after diagnosis].

Künzler A, Zindel A, Znoj HJ, Bargetzi M.

Praxis (Bern 1994). 2010 May 12;99(10):593-9. doi: 10.1024/1661-8157/a000122. German.

PMID:
20464690
44.

Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations.

Taverna C, Bargetzi M, Betticher D, Gmür J, Gregor M, Heim D, Hess U, Ketterer N, Lerch E, Matthes T, Mey U, Pabst T, Renner C.

Swiss Med Wkly. 2010 Sep 13;140:w13054. doi: 10.4414/smw.2010.13054. eCollection 2010. Review.

45.

Hematopoietic stem cell transplantation in Switzerland: a comprehensive quality control report on centre effect.

Passweg J, Baldomero H, Stern M, Bargetzi M, Ghielmini M, Leibundgut K, Duchosal M, Hess U, Seger R, Buhrfeind E, Schanz U, Gratwohl A; Swiss Blood and Marrow Stem Cells Transplant Group (SBST).

Swiss Med Wkly. 2010 Jun 12;140(23-24):326-34. doi: smw-12978.

46.

Who cares, who bears, who benefits? Female spouses vicariously carry the burden after cancer diagnosis.

Kuenzler A, Hodgkinson K, Zindel A, Bargetzi M, Znoj HJ.

Psychol Health. 2011 Mar;26(3):337-52. doi: 10.1080/08870440903418877. Epub 2010 Mar 19.

PMID:
20309780
47.

Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02).

Leupin N, Schuller JC, Solenthaler M, Heim D, Rovo A, Beretta K, Gregor M, Bargetzi MJ, Brauchli P, Himmelmann A, Hanselmann S, Zenhäusern R.

Leuk Lymphoma. 2010 Apr;51(4):613-9. doi: 10.3109/10428191003624231.

PMID:
20218808
48.

Weekly treatment with a combination of bortezomib and bendamustine in relapsed or refractory indolent non-Hodgkin lymphoma.

Moosmann P, Heizmann M, Kotrubczik N, Wernli M, Bargetzi M.

Leuk Lymphoma. 2010 Jan;51(1):149-52. doi: 10.3109/10428190903275602. No abstract available.

PMID:
19860608
49.

Toll-like receptor 4 gene polymorphism modulates phenotypic expression in patients with hereditary hemochromatosis.

Krayenbuehl PA, Hersberger M, Truninger K, Müllhaupt B, Maly FE, Bargetzi M, Schulthess G.

Eur J Gastroenterol Hepatol. 2010 Jul;22(7):835-41. doi: 10.1097/MEG.0b013e3283322067.

PMID:
19809335
50.

Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98).

Zenhäusern R, Schmitz SF, Solenthaler M, Heim D, Meyer-Monard S, Hess U, Leoncini L, Bargetzi M, Rufener B, Tobler A.

Leuk Lymphoma. 2009 Sep;50(9):1501-11. doi: 10.1080/10428190903131755.

PMID:
19672771

Supplemental Content

Loading ...
Support Center